Press release
Neuroprotection Therapeutics Market to Reach at USD 153.1 Billion by 2035 | Fact.MR Report
Neuroprotection Therapeutic Market
The size of the market is anticipated to grow from USD 75.0 billion in 2025 to USD 153.1 billion in 2035, exhibiting a CAGR of 7.4% during the forecast period. Alzheimer's, dementia, epilepsy, and multiple sclerosis are some of the long list of disorders that bode well for the neuroprotection therapeutics market that has been established.
Market trends are on an upward swing because of the growing findings and research that are being made available. Aging population globally and rising awareness of declining mental tolerance are fueling the growing awareness for neuroprotective therapy masterminding individuals to pursue either status assessment or meaningful action against illnesses such as Alzheimer's, dementia, epilepsy, and multiple sclerosis.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7564
Key Takeaways from Market Study:
The neuroprotection therapeutics market was valued at USD 53.3 billion in 2020.
It is estimated to reach USD 70.1 billion by 2024.
The market is projected to grow to USD 75.0 billion by 2025.
It is expected to further expand to USD 153.1 billion by 2035.
The historical CAGR from 2020 to 2024 was 6.6%.
The forecast CAGR from 2025 to 2035 is 7.4%.
Leading Players Driving Innovation in the Neuroprotection Therapeutic Market:
Allergan PLC | Daiichi Sankyo Co., Ltd. | Astrocyte Pharmaceuticals Inc. | AstraZeneca PLC | Biogen, Inc. | Novartis International AG | Eli Lilly and Company | F. Hoffmann-La Roche AG | Teva Pharmaceutical Industries Ltd. | Dr. Reddy's Laboratories Ltd.
Country-wise Outlook:
The neuroprotective therapeutics market in the United States is poised for substantial growth, driven by significant R&D investments, a robust pharmaceutical sector, and advanced healthcare infrastructure. The swift approval of innovative neuroprotective drugs by the FDA plays a crucial role in accelerating market expansion, ensuring timely access to treatments.
The rising prevalence of neurodegenerative diseases-such as Alzheimer's, which affected approximately 6.5 million individuals in 2023, and Parkinson's disease, impacting nearly 1 million-has created an urgent demand for disease-modifying therapies and novel treatment approaches.
Furthermore, collaborative efforts among biotech companies and research institutions are fueling investment in gene-based neurotherapeutics and regenerative medicine, boosting market potential. The U.S. neuroprotective therapeutics market is projected to be valued at USD 15.4 billion in 2025 and is anticipated to grow at a CAGR of 5.2%, reaching USD 25.4 billion by 2035.
Category-Wise Market Outlook:
Neurotrophic Factors (NTFs) are the most rapidly growing subsegment of products based on their new indication of nerve regeneration and neuroprotection. In contrast to conventional neuroprotective drugs with a symptom-relief profile, NTFs induce neuronal survival, repair, and regeneration and are highly promising in Alzheimer's disease, dementia, and multiple sclerosis.
Growth in the field of biotechnology and regenerative medicine as a result of higher investment in them and positive clinical trials is boosting the adoption of NTFs. Besides this, technology advancement in drug delivery and gene therapy is augmenting the efficiency of NTFs and therefore promoting market expansion.
Browse Full Report: https://www.factmr.com/report/neuroprotection-therapeutics-market
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the neuroprotection-treatment market, presenting historical data for 2020 to 2024 and forecast statistics for 2025 to 2035.
The neuroprotection therapeutics market is segmented across various categories to better understand its diverse applications and product offerings. By product type, the market includes free radical trapping agents (antioxidants), glutamate antagonists (anti-excitotoxic agents), apoptosis inhibitors, anti-inflammatory agents, neurotrophic factors (NTFs), and other specialized products.
In terms of medical conditions, the market addresses diseases such as Alzheimer's, dementia, epilepsy, and multiple sclerosis. Based on application, neuroprotective therapies are utilized for both prevention and treatment. By end user, hospitals, clinics, and other healthcare facilities represent key consumer bases for these therapies. Geographically, the market is distributed across North America, Latin America, Western and Eastern Europe, East Asia, South Asia & Pacific, and the Middle East & Africa, reflecting a global demand for effective neuroprotective solutions.
Check out More Related Studies Published by Fact.MR:
Rare Neurodegenerative Disease Treatment Market - https://www.factmr.com/report/5197/rare-neurodegenerative-disease-treatment-market
CNS Therapeutics Market - https://www.factmr.com/report/cns-therapeutics-market
Neuropathic Pain Market - https://www.factmr.com/report/neuropathic-pain-market
Brain Monitoring Devices Market - https://www.factmr.com/report/brain-monitoring-devices-market
Movement Disorder Market - https://www.factmr.com/report/329/movement-disorder-market
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroprotection Therapeutics Market to Reach at USD 153.1 Billion by 2035 | Fact.MR Report here
News-ID: 3958540 • Views: …
More Releases from Fact.MR Market Research
Undecylenic Acid Market Is Expected To Grow At A CAGR Of 4% During The Forecast …
Undecylenic acid, an unsaturated fatty acid derived from castor oil, is recognized for its antifungal properties. It is widely used in medical treatments for skin infections, as well as in the production of cosmetics and personal care products. The market is projected to witness higher single-digit growth globally during the forecast period, with regions like North America and Europe leading in volume, while the Middle East and Africa (MEA) are…
Whey Cheese Market to Reach USD 21.6 Billion by 2035 Amid Rising Demand for Func …
The global whey cheese market is witnessing remarkable growth, driven by increasing consumer preference for protein-rich, functional, and sustainable dairy products. According to recent research, the market is expected to reach USD 21.6 billion by 2035, up from USD 10.5 billion in 2024, marking a robust compound annual growth rate (CAGR) of 6.8% during the forecast period from 2025 to 2035.
Rising Demand for Functional and Protein-Rich Foods Fuels Market Expansion
The…
Enzyme-Enhanced Ingredients Market to Reach USD 11,657 Million by 2035, Driven b …
The global enzyme-enhanced ingredients market is poised for remarkable growth, with the industry projected to reach USD 11,657 million by 2035, up from USD 5,955 million in 2024. This expansion is expected to occur at a robust compound annual growth rate (CAGR) of 6.5% between 2025 and 2035.
The surge in demand is primarily driven by the rising adoption of enzyme-based solutions across food, beverage, and nutraceutical industries, alongside an…
Glycine Market Set to Reach USD 2,825.8 Million by 2035, Driven by Expanding App …
The global glycine market is poised for remarkable growth over the next decade, with market value projected to surge from USD 1,356.4 million in 2024 to USD 2,825.8 million by 2035.
During the forecast period from 2025 to 2035, the industry is expected to expand at a robust CAGR of 6.9%, reflecting the increasing demand for this versatile amino acid across multiple end-use sectors. Glycine, the simplest amino acid, is…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements
Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and…
